Saumya Sutaria, M.D., has been with Tenet Healthcare Corporation since 2018 and became CEO in September 2021. He holds impressive educational qualifications, including an M.D. from the University of California, San Diego, and dual degrees in economics and molecular biology...

Current Market Cap

$15.89B

Number of Employees

106.5K

Total Compensation

2021 - 2023

Trending up by 91.07% last year
Showing total compensation for the last 2021 - 2023

Stock

Up by 20.47% last year

Salary

Up by 4.08% last year

Bonus

Up by 0.00% last year

Other

Up by 40.36% last year

Year

2023

Total Compensation

$16.64M

Salary

$1.50M

Board Justification

The compensation philosophy aligns with company performance, peer benchmarking, and retention strategies, focusing on attracting and retaining talented executives with competitive pay.

Bonus

$6.30M

Board Justification

The bonus is based on the 2023 Annual Incentive Plan, with corporate performance achieved at 200% of target, and an individual performance multiplier of 140%.

Other

$587.72K

Board Justification

Includes matching contributions under the 401(k) Retirement Savings Plan, contributions under the Executive Retirement Account, and personal use of company aircraft.

Restricted Stock

$8.25M(109.15K RSU)

Board Justification

The stock awards granted in 2023 are time-based RSUs that vest ratably over three years, with a total grant date fair value of $6,500,002.

Performance Metrics

The performance metrics include Adjusted EBITDA and Adjusted Free Cash Flow less cash distributions paid to noncontrolling interests.

SEC Filing

From April 12, 2024

Saumya Sutaria

CEO of Tenet Healthcare

T

Education

M.D. from University of California, San Diego, BS in Molecular and Cellular Biology, BA in Economics from University of California, Berkeley

Field of Expertise

Healthcare & Life Sciences - Healthcare

Born

January 1, 1975 - 49 years ago

Is Founder?

No

Current Tenure

3 years 2 months (Sep 2021 - Present)

Previous Experience

COO of Tenet Healthcare Corporation, Senior Partner at McKinsey & Company

View Holdings

Insider Holdings of Saumya Sutaria

THC

$44.09M

$9.02M (25.71%)

Last Insider Trade

THC

$2.13M

THC at $154.93/share

Aug 14, 2024

Sale